AGARWAL SUNIL
Insider CIK 1616640 · ATXS Director · CALA Director · RARE Chief Medical Officer · MYOK Director · JUNO President of R & D · ARVN Director · SANA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 28,200 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2025-06-25 | 2025-06-30 | 23,105 | — | $0 | 23,105 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2025-06-25 | 2025-06-30 | 16,025 | — | $0 | 30,166 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 14,141 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-04-08 | 2024-04-09 | 28,200 | — | $0 | 28,200 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2023-06-15 | 2023-06-20 | 24,948 | — | $0 | 24,948 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2023-06-15 | 2023-06-20 | 8,242 | — | $0 | 8,242 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-03-03 | 2022-03-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2021-09-16 | 2021-09-17 | 1,627 | $26.00 | $42.3K | 1,550,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2021-09-15 | 2021-09-17 | 58,373 | $26.07 | $1.52M | 1,551,627 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-05 | 48,000 | — | $0 | 48,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-18 | 76,682 | — | $0 | 76,682 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 3,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 22,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 6,600 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | U Tender | 2020-11-17 | 2020-11-19 | 4,100 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 3,000 | — | $0 | 3,000 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 1,800 | — | $0 | 1,800 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 2,300 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 2,300 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 2,300 | — | $0 | 2,300 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 6,600 | — | $0 | 6,600 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2018-06-12 | 2018-06-14 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 313,797 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 35,893 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 84,549 | — | $0 | 65,028 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 29,135 | — | $0 | 35,893 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-31 | 2018-02-02 | 29,135 | — | $0 | 149,577 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-20 | 2017-10-20 | 35,893 | — | $0 | 120,442 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 7,285 | $44.76 | $326.1K | 84,549 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2017-06-14 | 2017-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-04-13 | 2017-04-17 | 313,797 | — | $0 | 313,797 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2017-04-13 | 2017-04-17 | 4,793 | $24.01 | $115.1K | 91,834 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-04-13 | 2017-04-17 | 96,627 | — | $0 | 96,627 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-08-19 | 2016-08-23 | 392 | $66.00 | $25.9K | 9,136 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-07-21 | 2016-07-21 | 649 | $52.68 | $34.2K | 9,528 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-07-19 | 2016-07-21 | 392 | $50.55 | $19.8K | 10,177 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-06-20 | 2016-06-21 | 650 | $54.16 | $35.2K | 10,569 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-06-19 | 2016-06-21 | 392 | $54.99 | $21.6K | 11,219 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2016-06-07 | 2016-06-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-01 | 2016-06-03 | 26,700 | — | $0 | 26,700 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-01 | 2016-06-03 | 4,500 | — | $0 | 11,611 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-05-24 | 2016-05-26 | 650 | $66.00 | $42.9K | 7,111 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-05-21 | 2016-05-23 | 414 | $64.01 | $26.5K | 7,761 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-05-19 | 2016-05-23 | 392 | $61.46 | $24.1K | 8,175 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-04-20 | 2016-04-21 | 649 | $70.53 | $45.8K | 8,567 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-04-19 | 2016-04-21 | 392 | $69.86 | $27.4K | 9,216 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-03-22 | 2016-03-24 | 650 | $61.45 | $39.9K | 9,608 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-03-19 | 2016-03-22 | 392 | $56.32 | $22.1K | 10,258 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2016-03-07 | 2016-03-08 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-02-22 | 2016-02-23 | 658 | $63.48 | $41.8K | 10,650 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-02-19 | 2016-02-23 | 384 | $63.27 | $24.3K | 11,308 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-01-20 | 2016-01-21 | 585 | $72.83 | $42.6K | 12,190 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-01-19 | 2016-01-21 | 456 | $71.52 | $32.6K | 12,775 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-22 | 2015-12-24 | 498 | $114.81 | $57.2K | 13,231 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2015-12-19 | 2015-12-22 | 544 | $109.87 | $59.8K | 13,729 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-11-23 | 2015-11-24 | 498 | $95.88 | $47.7K | 13,775 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2015-11-19 | 2015-11-23 | 544 | $97.71 | $53.2K | 14,273 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-10-20 | 2015-10-21 | 649 | $85.51 | $55.5K | 14,817 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2015-10-19 | 2015-10-21 | 392 | $88.94 | $34.9K | 15,466 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2015-09-29 | 2015-09-30 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-09-22 | 2015-09-24 | 498 | $109.51 | $54.5K | 15,858 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2015-09-19 | 2015-09-21 | 544 | $129.91 | $70.7K | 16,356 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2015-08-20 | 2015-08-21 | 10,000 | — | $0 | 140,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 3,370 | $112.19 | $378.1K | 20,550 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 724 | $107.30 | $77.7K | 26,176 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 930 | $111.90 | $104.1K | 16,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 2,000 | $111.21 | $222.4K | 17,830 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 4,875 | $110.40 | $538.2K | 19,830 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 1,471 | $108.98 | $160.3K | 24,705 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-20 | 2015-08-21 | 3,650 | $112.73 | $411.5K | 16,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2015-08-20 | 2015-08-21 | 10,000 | $55.88 | $558.8K | 26,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2015-08-19 | 2015-08-21 | 5,480 | $116.99 | $641.1K | 23,920 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-05-21 | 2015-05-27 | 26,300 | — | $0 | 26,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2015-05-21 | 2015-05-27 | 4,400 | — | $0 | 29,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2014-08-19 | 2014-08-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2014-08-19 | 2014-08-21 | 25,000 | — | $0 | 25,000 | SEC↗ |